It is widely accepted that the findings of
individual research studies are rarely sufficient
to justify new treatments. Systematic reviews identify, evaluate, combine and summarise the findings of all relevant individual studies and, when carried out well, provide decision makers with the best possible information about the effects of tests, treatments and other interventions used in health and social care. NETSCC manages the contracts for Reviews Infrastructure on behalf of NIHR.
Read the NIHR leaflet about Systematic Reviews 
View Professor Sally C. Davies video about NIHR Systematic Reviews 
UK Cochrane Centre and Cochrane Review Groups
The Cochrane Collaboration is the world’s largest organisation dedicated to producing and maintaining systematic reviews of the effects of healthcare interventions.
Worldwide more than 20,000 people are
involved in 52 Cochrane Review Groups in over 100 countries. Cochrane reviews are regularly updated and are valuable sources of information for those receiving care, as well as for decision-makers and researchers. There are now around 4,000 full Cochrane reviews available in The Cochrane Library, covering tens of thousands of research studies, millions of patients and billions of pounds of investment.
Twenty NIHR-funded Cochrane Review
Groups, all based in academic or health
institutions in the UK, cover a wide range
of areas of healthcare including dementia,
depression, heart disease, oral health,
palliative care, pregnancy and childbirth and
schizophrenia.
For more information, please visit : www.cochrane.co.uk
back to list 
Centre for Reviews and Dissemination
The Centre for Reviews and Dissemination (CRD), a department of the
University of York, is a centre of excellence in health research synthesis and a national resource for those who need to know about systematic reviews.
CRD undertakes systematic reviews across a
broad range of topic areas for national and
international funders and policy customers,
carries out methods research and produces
internationally accepted guidance for
undertaking systematic reviews.
For more information, please visit : www.york.ac.uk/inst/crd
back to list 
Diagnostic Test Evaluation Support Unit
Funding from the National Institute for Health Research (NIHR) has facilitated the establishment of the Diagnostic Test Evaluation Support Unit led by Professor Jon Deeks at the University of Birmingham. The activities have two main strands, (a) supporting UK based review groups in The Cochrane Collaboration in the implementation of Cochrane Systematic Reviews of Diagnostic Test Accuracy, (b) supporting the NIHR HTA programme in the commissioning of studies evaluating diagnostic test accuracy.
For more information, please visit : www.srdta.cochrane.org
back to list 
The unit for Improved Monitoring in Long Term Disease
The overall aim of this research programme is to improve understanding, methods, evidence-base and practice of clinical monitoring within the NHS. The short term aims include documenting and understanding the current practice gaps and variations. Based on important gaps identified, the project will develop and pilot new tools for monitoring. The medium term aims are to establish a UK-wide monitoring research network that will undertake both methodological and disease specific work. The long term aim is to make available, for each chronic disease, clearly identified current “best practice” monitoring processes and tools, and to ensure that there is active ongoing research in improving and implementing these across the NHS.
For more information, please visit : http://madox.org/
back to list 
Health Technology Assessment Reviews
Health Technology Assessment Reviews (TARs) provide a reliable and rigorous
evidence assessment of the benefits, harms and costs of particular healthcare
treatments and tests for those who plan, provide or receive care in the NHS.
TAR reports are commissioned to meet the urgent needs of national NHS decision-making bodies and policy customers. TARs are most commonly produced to inform NICE Appraisal Committee guidance on the use of new and existing medicines, treatments and procedures within the NHS in England and Wales.
Each TAR is tailored to meet the individual
policy customer’s needs in terms of independent evidence review, individual
patient meta-data analysis, cost-effectiveness
and economic modelling.
For more information, please visit : www.hta.ac.uk/about/NICE/index.shtml
back to list  |